Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...
The Spokesman-Review14h
FDA approves weight-loss drug Zepbound to treat sleep apnea
“(Friday’s) decision likely opens the door to Medicare coverage of an anti-obesity medication a bit wider than when the FDA ...
The American Journal of Managed Care14h
ICYMI: Highlights From AMCP Nexus 2024
The obesity epidemic in the US has been on the rise in years past, coinciding with an upward trend of anti-obesity ...
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
Woman's World on MSN2d
Weight Loss Drug Zepbound Could Treat Sleep Apnea Without a CPAP or Surgery
GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...
FDA approves anti-obesity drug as first sleep apnea medication
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
Stacker on MSN3d
The city where the most people have tried injectable weight loss medications—and see the rest of the top 50
The market for injectable weight loss medications has experienced rapid growth. Goldman Sachs Research predicts the global ...
Insurancenewsnet.com4d
Weight loss drugs changed their lives. Then they lost coverage
Mindy McCormick, 67, read that her insurer would soon stop covering the weight loss drug Wegovy, which she had been taking for more than two years. Nearly 9,000 people across the state had received ...
EconoTimes5d
Eli Lilly’s Zepbound Becomes FDA’s First Weight-Loss Drug Approved for Sleep Apnea Treatment
The FDA has approved Eli Lillys Zepbound as the first weight-loss drug to treat obstructive sleep apnea, reshaping care for ...
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
(Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for ...
Seafood recall in WA and Canada over norovirus risk
Oysters and manila clams harvested in Washington and British Columbia are being recalled. The FDA says the listed seafood ...